[Ceruloplasmin and peptides of medium molecular weight as parameters in development of acute myeloblastic leukemia].
A dynamic content of ceruloplasmin and medium-molecular peptides were studied in the blood serum of 28 patients with an acute clinical course of myeloblast-type leucosis during a scheduled chemotherapy. The mentioned biochemical criteria were shown to be able to characterize indirectly an intensity of the clinical course, functional liver condition and the efficiency of chemotherapy.